Skip to main content
Clinical Trials/NCT04667611
NCT04667611
Unknown
Not Applicable

Patient-reported Outcome Measures (PROMs) as Characteristics and Prognostic Factors in Patients With Bodily Stress Syndrome: Protocol for a Prospective Cohort Study

Helsinki University Central Hospital1 site in 1 country400 target enrollmentMarch 9, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fibromyalgia
Sponsor
Helsinki University Central Hospital
Enrollment
400
Locations
1
Primary Endpoint
Self-rated global health improvement
Last Updated
5 years ago

Overview

Brief Summary

This cohort study implements patient reported outcome measures (PROMs) for patients with bodily stress syndrome in a clinic for functional disorders.

Detailed Description

The Sympa Cohort study is a prospective, single site cohort study that consists of administration of PROMs questionnaires to patients that attend the Clinic for Functional Disorders at Helsinki University hospital (HUS). The questionnaires are handed out to the study population within seven days before their first visit at the clinic, and then at the following 3, 6 and 12 months. The study population consists of consecutive adult patients that are referred to the clinic either from other hospital units or primary care. The collected data will later be linked with national registries on diagnoses, medication use and work ability. The Sympa Cohort study may have implications in targeting the factors influencing functional outcomes and quality of life reported by patients with bodily stress syndrome. It will also form a quality register for the Clinic and characterize the first systematic collection of PROMs related to these disorders in Finland.

Registry
clinicaltrials.gov
Start Date
March 9, 2020
End Date
December 2023
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Helena Liira

Chief Physician

Helsinki University Central Hospital

Eligibility Criteria

Inclusion Criteria

  • All genders
  • Age 18-80 years
  • Referred to Clinic for Functional Disorders either from other hospital units or from primary care
  • Willingness to be enrolled in the study, by signing the informed consent

Exclusion Criteria

  • Patients not able to fill in the forms in Finnish or due to physical constraints (e.g. dystonia)
  • Symptoms are likely due to a somatic disorder

Outcomes

Primary Outcomes

Self-rated global health improvement

Time Frame: 12 months

Measured by clinical improvement scale (clinical global improvement, CGI), a five-point Likert scale

Functional ability

Time Frame: 12 months

Measured by WHODAS 2.0

Secondary Outcomes

  • EUROHIS-QOL-8(3, 6 and 12 months)
  • RS-14(3, 6 and 12 months)
  • PHQ-9(3, 6 and 12 months)
  • GAD-7(3, 6 and 12 months)
  • 15D(3, 6 and 12 months)
  • SSD-12(3, 6 and 12 months)

Study Sites (1)

Loading locations...

Similar Trials